Recombinant Proteins Market worth $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets™

Recombinant Proteins Market worth $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets™

PR Newswire

CHICAGO, Feb. 16, 2021

CHICAGO, Feb. 16, 2021 /PRNewswire/ -- According to the new market research report "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Academic Research), End User (Biotechnology Companies, CROs) - Global Forecast to 2026", published by MarketsandMarkets™, the global Recombinant Proteins Market is projected to reach USD 1.7 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 9.8% during the forecast period.


Browse in-depth TOC on "Recombinant Proteins Market"

100 – Tables 
33 – Figures
175 – Pages

Download PDF Brochure:

The Increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics are the major factors driving the growth of the market.

In 2020, the growth factors & chemokines segment accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period.

Based on product, the recombinant proteins market is classified into growth factors and chemokines, structural proteins, kinase proteins, regulatory proteins, membrane proteins, recombinant metabolic enzymes, adhesion molecules and receptors, immune response proteins, and other recombinant proteins. The large share of the growth factors and chemokines segment can be attributed to its use in various research areas such as chemotaxis, neurobiology, wound healing, immunology, transplantation, apoptosis, cancer, HIV/AIDS, COVID-19, cell culture, and stem cell research.

The drug discovery & development segment is expected to grow at the highest CAGR during the forecast period

Based on application, the recombinant proteins market is segmented into drug discovery & development, biopharmaceutical production, biotechnology research, academic research studies, and other applications. Drug discovery & development accounted for the largest share of the application segment in 2020 and is also expected to grow at the highest CAGR during the forecast period. As recombinant proteins are indispensable research tools in many areas of biology, they are essential and the most critical component of small molecule drug discovery programs. Recombinant proteins help to discover and develop new compounds that influence the function of disease-associated proteins. Increasing research & development in this segment is expected to have a positive impact on the overall growth of the market in the coming years.

Request Sample Pages:

North America was the largest regional market for the recombinant proteins in 2019

The recombinant proteins market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for market in 2020. The large share of the North American market can be attributed to the presence of the majority of major players operating in the market located in this region. Additionally, the rising incidences of chronic & infectious diseases, increasing R&D spending, increasing research activities in the fields of proteomics & genomics, and favorable government funding opportunities are other factors expected to boost the market for recombinant proteins in this region.

However, the Asia Pacific recombinant proteins market is estimated to grow at the highest CAGR during the forecast period.  The presence of emerging economies such as China, India, and South Korea; large population base and rising prevalence of chronic diseases in these countries; improving standards of living and the growing demand for quality medical care; increasing healthcare spending and government initiatives; growth in the demand for diagnostics; increasing research activities; and the rising number of collaborations for life science research studies are some of the major factors driving the growth of this regional market.

The global recombinant proteins market is fragmented. The prominent players operating in this market include Thermo Fisher Scientific, Inc. (US), Miltenyi Biotech (Germany), Sino Biological Inc. (China), Merck KGaA (Germany), Abcam plc (UK), Biolegend (US), Bio-Rad Laboratories, Inc. (US), GenScript Biotech Corporation (China), Enzo Life Sciences, Inc. (US), BPS Bioscience, Inc. (US), PeproTech, Inc. (US), Proteintech Group, Inc. (US), Abnova Corporation (Taiwan), R&D Systems (US), STEMCELL Technologies Inc (Canada), Other players operating in the market include RayBiotech Inc (US), CellGenix GmbH (Germany), ACROBiosystems (US), ProSpec-TechnoGene Ltd. (Israel), Neuromics (US), RICHCORE LIFESCIENCES PVT LTD (India), Icosagen AS (US), ProteoGenix (France), United States Biological (US), StressMarq Biosciences Inc (Canada), and Aviva Systems Biology Corporation (US).

Speak to Analyst:

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025

Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Research Insight: 
Visit Our Web Site: 
Content Source: 


Voltar noticias em Inglês